Jason Kerr

Jason Kerr is the current director at Freedom Holding. Prior to that, they worked as an external affairs quality specialist at Amgen from February 2018 to August 2020. In this role, they supported the company's intelligence program, ensuring compliance with GMP and GDP regulations. Jason also oversaw the OCI program vendor and partnered closely with key stakeholders such as Global Process Owners and the Commercial CI team. Jason also utilized data analytics software to provide better visualization of large amounts of intelligence data.

Prior to their work at Amgen, Jason was employed at PDA Southern California Chapter. In this role, they were responsible for collecting intelligence to ensure GXP compliance and provide insight into competitor's manufacturing capabilities. Jason also hosted the FDA in the emerging technology programs at PDA Southern California Chapter and published the Amgen GXP Intelligence on a monthly basis.

Jason Kerr has a Masters in Business and Science from Keck Graduate Institute, a Master of Business Administration from Quantic School of Business and Technology, and a Bachelor of Science in Biochemistry from University of California, Los Angeles. Jason also has a Certificate in Bioscience Industry Law and Practice from Southwestern Law School.